Dosage and administration
Apply to cleansed face and throat twice daily. Avoid eye area.
Apply to cleansed face and throat twice daily. Avoid eye area.
Drug Facts
Salicylic Acid (2.0%)
Acne treatment
For external use only
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Cyclopentasiloxane, Dimethicone Crosspolymer, C30-45 Alkyl Cetearyl Dimethicone Crosspolymer, Ethoxydiglycol, Cetyl Ethylhexanoate, Enantia Chlorantha Bark Extract, Cinnamomum Zeylanicum Bark Extract, Oleanolic Acid, Aesculus Hippocastanum (Horse Chestnut) Seed Extract, Camellia Oleifera Leaf Extract, Corallina Officinalis Extract, Chamomilla Recutita (Matricaria) Flower Extract, Vitis Vinifera (Grape) Seed Oil, Carthamus Tinctorius (Safflower) Seed Oil, Niacinamide, Yeast Extract, Zinc Gluconate, Caffeine, Biotin, Ammonium Glycyrrhizate, Stearyl Glycyrrhetinate, Sarcosine, Tocopheryl Acetate, Retinyl Palmitate, Panthenol, Lauryl PEG-9 Polydimethylsiloxyethyl Dimethicone, PTFE, Capryloyl Glycine, Butylene Glycol, Propylene Glycol, Water/Aqua/Eau.
Call toll free 1-800-831-5150 in the US
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68479-411-00 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-abbb-f424-e053-dadaa90a57ce | Clearing Mattifier |
| 68479-411-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-abbb-f424-e053-dadaa90a57ce | Clearing Mattifier |
| 68479-411-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-abbb-f424-e053-dadaa90a57ce | Clearing Mattifier |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68479-411-00 | Clearing Mattifier | 2 mL in 1 POUCH | LOTION | 2 | 2 | |
| 68479-411-01 | Clearing Mattifier | 14 mL in 1 TUBE | LOTION | 14 | 2 | |
| 68479-411-02 | Clearing Mattifier | 40 mL in 1 TUBE | LOTION | 40 | 2 | |
| 68479-411-02 | Clearing Mattifier | 1 in 1 CARTON | LOTION | 1 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Salicylic Acid | ACTIVE INGREDIENT | O414PZ4LPZ | 2 | |
| Salicylic Acid | ACTIVE MOIETY | O414PZ4LPZ | 2 | |
| .Alpha.-Tocopherol Acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 2 | |
| Ammonium Glycyrrhizate | INACTIVE INGREDIENT | 3VRD35U26C | 2 | |
| Annickia Chlorantha Bark | INACTIVE INGREDIENT | H70115MP4A | 2 | |
| Biotin | INACTIVE INGREDIENT | 6SO6U10H04 | 2 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 2 | |
| Caffeine | INACTIVE INGREDIENT | 3G6A5W338E | 2 | |
| Camellia Oleifera Leaf | INACTIVE INGREDIENT | 5077EL0C60 | 2 | |
| Capryloyl Glycine | INACTIVE INGREDIENT | 8TY5YO42NJ | 2 | |
| Cetyl Ethylhexanoate | INACTIVE INGREDIENT | 134647WMX4 | 2 | |
| Chamomile | INACTIVE INGREDIENT | FGL3685T2X | 2 | |
| Cinnamon Bark Oil | INACTIVE INGREDIENT | XE54U569EC | 2 | |
| Corallina Officinalis | INACTIVE INGREDIENT | 4004498D06 | 2 | |
| Cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 2 | |
| Diethylene Glycol Monoethyl Ether | INACTIVE INGREDIENT | A1A1I8X02B | 2 | |
| Grape Seed Oil | INACTIVE INGREDIENT | 930MLC8XGG | 2 | |
| Horse Chestnut | INACTIVE INGREDIENT | 3C18L6RJAZ | 2 | |
| Lauryl PEG-9 Polydimethylsiloxyethyl Dimethicone | INACTIVE INGREDIENT | 25G622K2RA | 2 | |
| Niacinamide | INACTIVE INGREDIENT | 25X51I8RD4 | 2 | |
| Oleanolic Acid | INACTIVE INGREDIENT | 6SMK8R7TGJ | 2 | |
| Panthenol | INACTIVE INGREDIENT | WV9CM0O67Z | 2 | |
| POLYTETRAFLUOROETHYLENE | INACTIVE INGREDIENT | E1NC1JVS3O | 2 | |
| Propylene Glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| Safflower Oil | INACTIVE INGREDIENT | 65UEH262IS | 2 | |
| Sarcosine | INACTIVE INGREDIENT | Z711V88R5F | 2 | |
| Stearyl Glycyrrhetinate | INACTIVE INGREDIENT | 3YYE6VJS0P | 2 | |
| Vitamin A Palmitate | INACTIVE INGREDIENT | 1D1K0N0VVC | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 | |
| Yeast, Unspecified | INACTIVE INGREDIENT | 3NY3SM6B8U | 2 | |
| Zinc Gluconate | INACTIVE INGREDIENT | U6WSN5SQ1Z | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68479-411 | 68479-411-02, 68479-411-01, 68479-411-00 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAMUSCULAR | 7459 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / SUBLINGUAL | 36 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAVENOUS | 16624 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CONCENTRATE / ORAL | 7000 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / AURICULAR (OTIC) | 56.55 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / TOPICAL | 8 %w/w | ||
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | GEL / TOPICAL | 25 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / SUBCUTANEOUS | 1.4 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SYSTEM / TOPICAL | 4200 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / ORAL | 22602 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| Caffeine | CAFFEINE | 3G6A5W338E | SPRAY, METERED / NASAL | 10 mg/1ml | ||
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| Diethylene Glycol Monoethyl Ether | DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | GEL / TRANSDERMAL | 87 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | 27 mg | ||
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | CREAM / TOPICAL | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUPPOSITORY / VAGINAL | 252 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / DENTAL | 2 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM, AUGMENTED / TOPICAL | 8 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / RESPIRATORY (INHALATION) | 10 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | 4000 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / VAGINAL | 750 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| Caffeine | CAFFEINE | 3G6A5W338E | SOLUTION / OPHTHALMIC | 2 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TOPICAL | 4522 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / ORAL | 29008 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED / ORAL | 25 mg | ||
| Diethylene Glycol Monoethyl Ether | DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | SYSTEM / TOPICAL | 1720 mg | ||
| Diethylene Glycol Monoethyl Ether | DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | OINTMENT / TOPICAL | 5 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / INTRAVENOUS | 50.33 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | DROPS / ORAL | 200 mg/1ml | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TRANSDERMAL | 500 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL, METERED / TOPICAL | 1225 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / DENTAL | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPONGE / TOPICAL | 40 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, METERED / RECTAL | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SHAMPOO / TOPICAL | 8 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SWAB / TOPICAL | 34.6 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY, METERED / NASAL | 240 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAMUSCULAR | 4000 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / RESPIRATORY (INHALATION) | 25 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / RECTAL | 90400 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / INTRAVENOUS | 5 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / TOPICAL | 4886 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SHAMPOO, SUSPENSION / TOPICAL | 2 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / OPHTHALMIC | 1.5 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CLOTH / TOPICAL | 0.03 mg/mg | ||
| Diethylene Glycol Monoethyl Ether | DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | CREAM / TOPICAL | 1290 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION / TOPICAL | 3392 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3375a90f-3667-4e8f-be9a-cd950be24242 | 2f106903-df34-49b5-84a1-dbad9b92c5d3 | 2015-11-20 | Warnings | 3375a90f-3667-4e8f-be9a-cd950be24242 2f106903-df34-49b5-84a1-dbad9b92c5d3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.